COVID-19 Update: We are currently shipping orders daily. However, due to transit disruptions in some geographies, deliveries may be delayed. To provide all customers with timely access to content, we are offering 50% off Science and Technology Print & eBook bundle options. Terms & conditions.
Fundamentals of Biologicals Regulation - 1st Edition - ISBN: 9780128092903, 9780128094433

Fundamentals of Biologicals Regulation

1st Edition

Vaccines and Biotechnology Medicines

Author: Rebecca Sheets
Paperback ISBN: 9780128092903
eBook ISBN: 9780128094433
Imprint: Academic Press
Published Date: 1st December 2017
Page Count: 450
Sales tax will be calculated at check-out Price includes VAT/GST
Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.


Fundamentals of Biologicals Regulation: Vaccines and Biotechnology Medicines serves as an introduction to the international regulatory arena in which biologicals are developed and offers an overview of the processes and insight into the scientific concepts underpinning global regulations. This book will provide multiple levels of readership with guidance on basic concepts, a detailed look at regulatory challenges, and practical insight into how regulators consider regulatory science and regulatory process issues across various regions. With numerous case studies, learning activities, and real-world examples across several classes of biotechnological products, this book is a valuable and comprehensive resource for graduate students, professors, regulatory officials, and industry scientists working with biologicals.

Key Features

  • Provides a broad overview and introduction to the regulatory processes, from product development pathways, through clinical trials and product development stages and beyond
  • Includes FDA, EMA, ICH, and WHO recommendations and guidelines so readers can compare and contrast the different regulatory regions with their expectations and understand why they are different
  • Contains chapters on some of the exceptions to the process including how biosimilars and in vitro diagnostics are regulated
  • Includes numerous case studies, learning activities, and real-world examples across several classes of biotechnological products


Graduate students and professors in biotechnology, pharmaceutical science and regulatory science programs, regulatory officials, industry professionals

Table of Contents

Section I: Regulatory Process

1. Introduction
2. Discovery and Development of Biologicals
3. International Harmonization
4. Pre-IND Profess, Guidance from Regulators in Advance of a Clinical Trials Application
5. Clinical Trials Approvals and Investigational New Drug Applications
6. Marketing Authorization Processes
7. Special Regulatory Programs
8. Post-Marketing Changes to an Approved Application or Variations
9. Compliance and Inspections
10. Good "X" Practices

Section II: Regulatory Science

11. Preclinical Safety and Toxicology
12. Preclinical Proof-of-Concept and Pharmacology, Animal Use Ethics
13. Genetically Modified Organisms and Institutional Biosafety Committees
14. Risk Assessments
15. Chemistry, Manufacturing, and Controls Information (CMC) and Process Validation
16. Analytics, Analytical Validation, Lot Release, and National Control Laboratories
17. Regulatory Aspects of Clinical Trials
18. Ethics of Clinical Trials and the Informed Consent Process
19. Institutional Review Board Processes (Ethics Committees)
20. Biosimilars
21. In Vitro Diagnostics
22. Regulatory Policy and Public Health Policy


No. of pages:
© Academic Press 2017
1st December 2017
Academic Press
Paperback ISBN:
eBook ISBN:

About the Author

Rebecca Sheets

• Currently a board member and Executive Committee Member (Vice President for Human Biologicals) of the International Alliance of Biologicals Standardization • Former Vaccine Scientific and Regulatory Specialist at the National Institute of Allergy and Infectious Diseases • Served 9 years as a Scientific Reviewer in the Viral Vaccines branch of the Division of Vaccines and Related Products Applications at the Center for Biologics Evaluation and Research at the FDA • From 2006-2014, served as Co-Chair of the World Health Organization’s Study Group on Cell Substrates and as Chair of the Adventitious Agents Sub-committee.

Affiliations and Expertise

Principal Consultant and Subject Matter Expert, Grimalkin Partners, Silver Spring, MD; Adjunct Professor, Catholic University of America

Ratings and Reviews